{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:24:18Z","timestamp":1776939858750,"version":"3.51.4"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["2021-SGR-01293"],"award-info":[{"award-number":["2021-SGR-01293"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201904\u201330"],"award-info":[{"award-number":["201904\u201330"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI22\/00203"],"award-info":[{"award-number":["PI22\/00203"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013816","name":"Generalitat de Catalunya Departament d'Empresa i Coneixement","doi-asserted-by":"publisher","award":["2018-BP-00055"],"award-info":[{"award-number":["2018-BP-00055"]}],"id":[{"id":"10.13039\/501100013816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.beha.2023.101513","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:57:36Z","timestamp":1696921056000},"page":"101513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cytogenomics of B-cell non-Hodgkin lymphomas: The \u201cold\u201d meets the \u201cnew\u201d"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-0387","authenticated-orcid":false,"given":"Marta","family":"Grau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ignacio","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2023.101513_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.beha.2023.101513_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ijc.2910170108","article-title":"Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with burkitt and non-burkitt lymphomas","volume":"17","author":"Zech","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2023.101513_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib4","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.beha.2023.101513_bib5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib7","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib8","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2006-02-005322","article-title":"Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression","volume":"108","author":"Dicker","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib9","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101513_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.22994","article-title":"Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia","volume":"61","author":"Costa","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2023.101513_bib11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.23618","article-title":"Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data","volume":"89","author":"Baliakas","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2023.101513_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41375-019-0533-6","article-title":"The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab","volume":"34","author":"Kreuzer","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101513_bib15","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/cancers14143376","article-title":"Optical genome mapping: a promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL)","volume":"14","author":"Puiggros","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.beha.2023.101513_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2141.2010.08299.x","article-title":"Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms","volume":"151","author":"Reindl","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101513_bib17","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib18","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib19","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2023.101513_bib21","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2023.101513_bib22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib24","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.3324\/haematol.2018.214957","article-title":"Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses","volume":"104","author":"Cascione","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib25","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2023.101513_bib26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.2021012386","article-title":"Genetic and phenotypic attributes of splenic marginal zone lymphoma","volume":"139","author":"Bonfiglio","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib27","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2023.101513_bib28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3324\/haematol.2018.191601","article-title":"Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites","volume":"103","author":"Moody","year":"2018","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.beha.2023.101513_bib29","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cancers12040986","article-title":"Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the MALT subtype by whole genome, whole exome and targeted sequencing","volume":"12","author":"Johansson","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.beha.2023.101513_bib31","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sol\u00e9","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bjh.17141","article-title":"Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities","volume":"193","author":"Gailllard","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101513_bib33","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.leu.2404695","article-title":"A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation","volume":"21","author":"Mart\u00edn-Subero","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/sj.leu.2405027","article-title":"The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma","volume":"22","author":"Remstein","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib35","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","article-title":"The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance","volume":"127","author":"Zucca","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2023.101513_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/sj.leu.2401918","article-title":"Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma","volume":"14","author":"Kalla","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib37","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib38","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.pas.0000213275.60962.2a","article-title":"The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America","volume":"30","author":"Remstein","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3324\/haematol.2011.052639","article-title":"t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34","volume":"97","author":"Baens","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib41","doi-asserted-by":"crossref","first-page":"62627","DOI":"10.18632\/oncotarget.11548","article-title":"Recurrent mutations in NF-kB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.beha.2023.101513_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2559.2005.02309.x","article-title":"A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases","volume":"48","author":"Traverse-Glehen","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2023.101513_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.22004","article-title":"t(11;14)(q23;q32) involving IGH and DDX6 in nodal marginal zone lymphoma","volume":"52","author":"Stary","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2023.101513_bib44","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib45","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.82.21.7439","article-title":"Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18","volume":"82","author":"Cleary","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2023.101513_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","article-title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","volume":"113","author":"Cheung","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib47","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib48","first-page":"595","article-title":"Molecular pathogenesis of follicular lymphoma: from genetics to clinical practice","volume":"3","author":"L\u00f3pez","year":"2022","journal-title":"Hematology (N Y)"},{"key":"10.1016\/j.beha.2023.101513_bib49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bjh.17383","article-title":"Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation","volume":"194","author":"Kumar","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101513_bib50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","article-title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","volume":"129","author":"Krysiak","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib52","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2023.101513_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.beha.2023.101513_bib54","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.beha.2023.101513_bib56","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2023.101513_bib57","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"34","author":"Navarro","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.beha.2023.101513_bib58","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1\u2212 mantle cell lymphoma","volume":"133","author":"Mart\u00edn-Garcia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2023.101513_bib60","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/10428190290016890","article-title":"Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases","volume":"43","author":"Au","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2023.101513_bib61","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib62","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib63","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-004-0879-2","article-title":"Coexistence of BCL1\/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome","volume":"83","author":"Michaux","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2023.101513_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153283","article-title":"Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma","volume":"132","author":"Yi","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2023.101513_bib65","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2018-03-838136","article-title":"A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome","volume":"132","author":"Clot","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib66","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib67","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101513_bib68","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2023.101513_bib69","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2023.101513_bib70","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the lunenburg lymphoma biomarker consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101513_bib71","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3324\/haematol.2019.227892","article-title":"Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study","volume":"105","author":"Bolen","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib72","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib73","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib74","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2023.101513_bib75","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101513_bib76","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2023.101513_bib77","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1200\/JCO.2010.32.8385","article-title":"The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective","volume":"29","author":"Salaverria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101513_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib79","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"L\u00f3pez","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2023.101513_bib80","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bjh.17922","article-title":"Epstein-Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes","volume":"196","author":"Leoncini","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101513_bib81","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beha.2023.101513_bib82","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib83","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101513_bib84","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1038\/s41467-022-31355-8","article-title":"Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age","volume":"13","author":"Burkhardt","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2023.101513_bib85","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Scholtysik","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib86","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101513_bib88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","article-title":"Burkitt lymphoma","volume":"8","author":"L\u00f3pez","year":"2022","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.beha.2023.101513_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib90","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/pin.13067","article-title":"B cell lymphoma with IRF4 rearrangement: a clinicopathological study of 13 cases","volume":"71","author":"Zhou","year":"2021","journal-title":"Pathol Int"},{"key":"10.1016\/j.beha.2023.101513_bib93","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.22014","article-title":"High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas","volume":"52","author":"Salaverria","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2023.101513_bib94","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib95","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2017.186","article-title":"A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","volume":"31","author":"Rymkiewicz","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-gain\/loss aberration occurs recurrently in MYC-negative burkitt-like lymphoma with 11q aberration, as well as MYC-positive burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib97","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib98","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.humpath.2018.06.006","article-title":"Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations","volume":"80","author":"Johnson","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beha.2023.101513_bib100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2404529","article-title":"Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas","volume":"21","author":"Bertrand","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib101","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the lunenburg lymphoma biomarker consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101513_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ejh.12212","article-title":"MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC\/BCL2 translocations","volume":"92","author":"Pedersen","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2023.101513_bib103","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2018.198572","article-title":"Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"104","author":"Evrard","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib104","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3324\/haematol.2021.279631","article-title":"Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and\/or BCL6 rearrangements characterized by whole-exome sequencing","volume":"107","author":"K\u00fcnstner","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101513_bib105","first-page":"781","article-title":"Characterization of the genetic landscape of High-grade B-cell lymphoma, NOS - an LLMPP project","volume":"39","author":"Collinge","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.beha.2023.101513_bib106","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2023.101513_bib107","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2023.101513_bib108","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","article-title":"Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage","volume":"30","author":"Queir\u00f3s","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2023.101513_bib111","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/leu.2014.252","article-title":"A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact","volume":"29","author":"Queir\u00f3s","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101513_bib112","first-page":"585","article-title":"Identification of 2 DNA methylation subtypes of Waldenstr\u00f6m macroglobulinemia with plasma and memory B-cell features","volume":"136","author":"Roos-Weil","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101513_bib113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-020-00752-3","article-title":"A comparison of epigenetic mitotic-like clocks for cancer risk prediction","volume":"12","author":"Teschendorff","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.beha.2023.101513_bib114","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41588-018-0073-4","article-title":"DNA methylation loss in late-replicating domains is linked to mitotic cell division","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101513_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13059-016-1064-3","article-title":"Correlation of an epigenetic mitotic clock with cancer risk","volume":"17","author":"Yang","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.beha.2023.101513_bib116","first-page":"1066","article-title":"The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome","volume":"1","author":"Duran-Ferrer","year":"2020","journal-title":"Nat Can (Ott)"},{"key":"10.1016\/j.beha.2023.101513_bib117","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","article-title":"The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia","volume":"24","author":"Beekman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2023.101513_bib118","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-020-20849-y","article-title":"Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation","volume":"12","author":"Vilarrasa-Blasi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2023.101513_bib119","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:08:38Z","timestamp":1761498518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692623000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521692623000749"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2023.101513","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenomics of B-cell non-Hodgkin lymphomas: The \u201cold\u201d meets the \u201cnew\u201d","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2023.101513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101513"}}